ICONIQ Capital LLC Invests $312,000 in HCA Healthcare, Inc. $HCA

Key Points

• ICONIQ Capital LLC invested approximately $312,000 in HCA Healthcare, acquiring 902 shares, reflecting growing interest from various institutional investors in the company's stock.
• HCA Healthcare's stock has a consensus rating of "Moderate Buy" with a target price averaging $398.58, despite recent price target cuts from major analysts.
• The company recently announced a quarterly dividend of $0.72 per share, reflecting a yield of 0.7% and a payout ratio of 12.11%.

ICONIQ Capital LLC bought a new position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 902 shares of the company's stock, valued at approximately $312,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Cheviot Value Management LLC bought a new stake in HCA Healthcare during the first quarter worth approximately $26,000. Atwood & Palmer Inc. acquired a new position in shares of HCA Healthcare in the 1st quarter worth $28,000. Bartlett & CO. Wealth Management LLC lifted its holdings in shares of HCA Healthcare by 888.9% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock valued at $31,000 after purchasing an additional 80 shares during the last quarter. ORG Partners LLC increased its stake in HCA Healthcare by 344.0% in the 1st quarter. ORG Partners LLC now owns 111 shares of the company's stock worth $38,000 after purchasing an additional 86 shares in the last quarter. Finally, Migdal Insurance & Financial Holdings Ltd. lifted its stake in HCA Healthcare by 75.8% during the first quarter. Migdal Insurance & Financial Holdings Ltd. now owns 116 shares of the company's stock valued at $40,000 after buying an additional 50 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on the stock. Barclays cut their price target on shares of HCA Healthcare from $416.00 to $390.00 and set an "overweight" rating on the stock in a report on Monday, July 28th. Morgan Stanley decreased their target price on HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating for the company in a research report on Monday, July 28th. Wolfe Research downgraded HCA Healthcare from an "outperform" rating to a "peer perform" rating in a research note on Monday, July 28th. Wall Street Zen upgraded HCA Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, July 5th. Finally, Truist Financial boosted their price objective on shares of HCA Healthcare from $390.00 to $415.00 and gave the company a "buy" rating in a research report on Wednesday, July 16th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $398.58.

HCA Healthcare Stock Down 0.5%

Shares of HCA opened at $403.0620 on Tuesday. The business's fifty day moving average price is $374.60 and its two-hundred day moving average price is $354.80. The firm has a market capitalization of $94.31 billion, a price-to-earnings ratio of 16.94, a PEG ratio of 1.27 and a beta of 1.39. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.86 and a current ratio of 0.98. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, beating the consensus estimate of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The firm had revenue of $18.61 billion during the quarter, compared to the consensus estimate of $18.49 billion. During the same quarter in the prior year, the firm earned $5.50 earnings per share. The business's quarterly revenue was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th will be paid a $0.72 dividend. The ex-dividend date is Tuesday, September 16th. This represents a $2.88 dividend on an annualized basis and a yield of 0.7%. HCA Healthcare's dividend payout ratio is 12.11%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.